Henri J Vial

Author PubWeight™ 27.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 2002 2.27
2 In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism. Antimicrob Agents Chemother 2003 1.25
3 Phosphatidylinositol 3-phosphate, an essential lipid in Plasmodium, localizes to the food vacuole membrane and the apicoplast. Eukaryot Cell 2010 1.16
4 Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 2004 1.16
5 Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob Agents Chemother 2003 1.14
6 Glycerophospholipid acquisition in Plasmodium - a puzzling assembly of biosynthetic pathways. Int J Parasitol 2010 1.04
7 Symmetrical choline-derived dications display strong anti-kinetoplastid activity. J Antimicrob Chemother 2010 1.01
8 Phosphatidylinositol 3-monophosphate is involved in toxoplasma apicoplast biogenesis. PLoS Pathog 2011 0.99
9 Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp. Antimicrob Agents Chemother 2006 0.96
10 Quantitative assessment of DNA replication to monitor microgametogenesis in Plasmodium berghei. Mol Biochem Parasitol 2009 0.92
11 Multiple roles for Plasmodium berghei phosphoinositide-specific phospholipase C in regulating gametocyte activation and differentiation. Cell Microbiol 2011 0.92
12 Rodent and nonrodent malaria parasites differ in their phospholipid metabolic pathways. J Lipid Res 2010 0.90
13 The Kennedy phospholipid biosynthesis pathways are refractory to genetic disruption in Plasmodium berghei and therefore appear essential in blood stages. Mol Biochem Parasitol 2010 0.89
14 A 24 bp cis-acting element essential for the transcriptional activity of Plasmodium falciparum CDP-diacylglycerol synthase gene promoter. Mol Biochem Parasitol 2002 0.88
15 Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria. Antimicrob Agents Chemother 2008 0.88
16 Dual molecules as new antimalarials. Comb Chem High Throughput Screen 2005 0.87
17 A novel live-dead staining methodology to study malaria parasite viability. Malar J 2013 0.85
18 Genetic and transcriptional analysis of phosphoinositide-specific phospholipase C in Plasmodium. Exp Parasitol 2011 0.80
19 Characterisation of the phosphatidylinositol synthase gene of Plasmodium species. Res Microbiol 2006 0.80
20 Quantification of antimalarial bisthiazolium compounds and their neutral bioprecursors in plasma by liquid chromatography-electrospray mass spectrometry. Clin Chem 2005 0.79
21 Characterization of choline uptake in Trypanosoma brucei procyclic and bloodstream forms. Mol Biochem Parasitol 2013 0.79
22 Pharmacological properties of a new antimalarial bisthiazolium salt, T3, and a corresponding prodrug, TE3. Antimicrob Agents Chemother 2005 0.78
23 New bis-thiazolium analogues as potential antimalarial agents: design, synthesis, and biological evaluation. J Med Chem 2013 0.78
24 PG12, a phospholipid analog with potent antimalarial activity, inhibits Plasmodium falciparum CTP:phosphocholine cytidylyltransferase activity. J Biol Chem 2011 0.78
25 Liquid chromatography-electrospray mass spectrometry determination of a bis-thiazolium compound with potent antimalarial activity and its neutral bioprecursor in human plasma, whole blood and red blood cells. J Chromatogr B Analyt Technol Biomed Life Sci 2005 0.78
26 Plasmodium CDP-DAG synthase: an atypical gene with an essential N-terminal extension. Int J Parasitol 2010 0.78
27 Quantitation of SAR97276 in mouse tissues by rapid resolution liquid chromatography-mass spectrometry. J Sep Sci 2009 0.78
28 Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activities. J Med Chem 2012 0.76
29 Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria. Nat Commun 2017 0.75
30 Kinetic modelling of phospholipid synthesis in Plasmodium knowlesi unravels crucial steps and relative importance of multiple pathways. BMC Syst Biol 2013 0.75
31 Pharmacokinetic properties and metabolism of a new potent antimalarial N-alkylamidine compound, M64, and its corresponding bioprecursors. Eur J Pharm Sci 2010 0.75